Innovation Powered by In-House Expertise and Leadership
At Envello, all of our innovation is driven in-house. Led by a team with expertise in business, startups, and engineering, we are guided by seasoned entrepreneurs, clinicians and academics. Our design, prototyping, and quality control processes are managed by an experienced team of engineers who understand how to take advanced technologies and operationalize them into real medical scenarios.
.png)
About Envello
Envello is a subsidiary company of NIRSense, a medical device company founded in 2018 that was contracted by the Department of Defense to help protect the health of U.S. warfighters. The U.S. military needs reliable, durable, and mobile devices that can monitor -- and help prevent -- serious conditions including hemorrhage-related deaths and cognitive impairment in fighter pilots at high altitudes, in combat divers at deep depths, and on the battlefield in traumatic bleeding situations.
NIRSense has received over $28M in competitively awarded development contracts and continues to innovate in support of the unique needs of the U.S. government.
Envello is focused on the design, development, and commercialization of innovative scalable, non-invasive monitoring technologies with the potential to improve patient outcomes while reducing footprint and costs. Envello is initially focused on continuous monitoring of tissue oximetry in patients at risk of cardiovascular conditions including heart failure and ST-segment elevation myocardial infarction (STEMI).
Our Leadership Team
Dr. Boutwell’s research background focused on optical sensor development. His professional experience includes intellectual property strategy, technology licensing/negotiation, and business development. He contributes his technical expertise in optoelectronics; business experience in technology commercialization, intellectual property, and licensing strategy; and professional network in digital health and wearable biosensing systems.
Ms. Kimberly’s expertise in operations and administration began by providing executive support in the U.S. Air Force. She is broadly skilled and process-oriented, focusing on operations optimization and process flow, managing stakeholder communications and contractor engagement.
Mr. Rodenhaver is a 20-year veteran of the medical device industry with extensive sales, marketing, and product launch experience. As a previous startup founder he brings start-up and growth knowledge to the leadership team. Mr. Rodenhaver is leveraging his network and industry experience to guide Envello's user focused design approach and identify the ideal markets for our technology.
Our Advisers
Section Head, Advanced Heart Failure, Transplant and MCS
Heart Vascular and Thoracic Institute
Cleveland Clinic Florida
Cardiovascular Clinical Pharmacist/VP Operations and System Cardiovascular Services Executive
Baptist Health
Cardiothoracic Transplant, MCS & AHF Program Manager
Transplant Center
University of Utah
Principal and Practice Lead, Management and Health Strategy, M&A Advisory Services
Mountains Call Consulting, LLC
Interested in Research, Collaboration, or Investment?
As Envello enters a phase of rapid growth, we are interested in strategic partners who share our vision and goals to help expand our reach and bring our groundbreaking monitoring solutions to patients worldwide. If you are interested in collaborating, please fill out the below form and our team will get in touch with you soon.